Global Herceptin (Trastuzumab) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Herceptin (Trastuzumab) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Herceptin (Trastuzumab) is a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor from attaching to Her2. Herceptin also stimulates the body's own immune cells to destroy cancer cells. Clinically, it is mainly used for metastatic breast cancer with excessive expression of her-2. Monotherapy may be used for metastatic breast cancer that has received one or more chemotherapy regimens; It can be combined with paclitaxel to treat metastatic breast cancer without chemotherapy.
Herceptin (Trastuzumab) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Herceptin (Trastuzumab) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Medical Center are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Herceptin (Trastuzumab) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Herceptin (Trastuzumab) key manufacturers include Roche Diagnostics, Genentech, Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited and Bio-Techne, etc. Roche Diagnostics, Genentech, Novartis AG are top 3 players and held % sales share in total in 2022.
Herceptin (Trastuzumab) can be divided into Breast Cancer, Stomach Cancer and Others,, etc. Breast Cancer is the mainstream product in the market, accounting for % sales share globally in 2022.
Herceptin (Trastuzumab) is widely used in various fields, such as Hospital and Medical Center, etc. Hospital provides greatest supports to the Herceptin (Trastuzumab) industry development. In 2022, global % sales of Herceptin (Trastuzumab) went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Herceptin (Trastuzumab) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Roche Diagnostics
Genentech
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Amgen
Samsung Bioepis
Merck
Mylan
Teva Pharmaceutical
Mundipharma
Mabion
AryoGen Biopharma
Genor Biopharma
Segment by Type
Breast Cancer
Stomach Cancer
Others
Hospital
Medical Center
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Herceptin (Trastuzumab) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Herceptin (Trastuzumab), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Herceptin (Trastuzumab) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Herceptin (Trastuzumab) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Herceptin (Trastuzumab) introduction, etc. Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Herceptin (Trastuzumab) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Herceptin (Trastuzumab) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Herceptin (Trastuzumab) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Medical Center are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Herceptin (Trastuzumab) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Herceptin (Trastuzumab) key manufacturers include Roche Diagnostics, Genentech, Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited and Bio-Techne, etc. Roche Diagnostics, Genentech, Novartis AG are top 3 players and held % sales share in total in 2022.
Herceptin (Trastuzumab) can be divided into Breast Cancer, Stomach Cancer and Others,, etc. Breast Cancer is the mainstream product in the market, accounting for % sales share globally in 2022.
Herceptin (Trastuzumab) is widely used in various fields, such as Hospital and Medical Center, etc. Hospital provides greatest supports to the Herceptin (Trastuzumab) industry development. In 2022, global % sales of Herceptin (Trastuzumab) went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Herceptin (Trastuzumab) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Roche Diagnostics
Genentech
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Amgen
Samsung Bioepis
Merck
Mylan
Teva Pharmaceutical
Mundipharma
Mabion
AryoGen Biopharma
Genor Biopharma
Segment by Type
Breast Cancer
Stomach Cancer
Others
Segment by Application
Hospital
Medical Center
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Herceptin (Trastuzumab) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Herceptin (Trastuzumab), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Herceptin (Trastuzumab) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Herceptin (Trastuzumab) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Herceptin (Trastuzumab) introduction, etc. Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Herceptin (Trastuzumab) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices